Drug
Eloralintide
Eloralintide: highest development phase Phase 3, developed by Eli Lilly. 1 trial record tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- Eli Lilly
Trials
| Drug | Phase | Indication |
|---|---|---|
| Eloralintide NCT07353931 | Phase 3 | Osteoarthritis |
Latest
No recent events.
Follow Eloralintide on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.